Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells Activation in Vivo Increases Blood Leukocyte Counts and Its Blockade Abrogates 13,14-Dihydro-15-keto-prostaglandin D2-Induced Eosinophilia in Rats
- 1 November 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 307 (2) , 518-525
- https://doi.org/10.1124/jpet.103.055442
Abstract
We cloned, expressed, and characterized in vitro and in vivo the gene encoding the rat ortholog of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2), a G protein-coupled receptor for prostaglandin D2 (PGD2). Quantitative reverse transcription-polymerase chain reaction analysis demonstrated highest CRTH2 expression in the lung, brain, ovary, and spleen. Pharmacologically, rat CRTH2 stably transfected in mouse preB lymphoma L1.2 cells behaved very similar compared with the mouse and human orthologs, showing a binding affinity for PGD2 of 11 nM, a functional calcium mobilization when exposed to agonist, and similar sensitivity to agonists and antagonists. In vivo, selective activation of CRTH2 by 13,14-dihydro-15-keto (DK)-PGD2 injection into rats led to a dose- and time-dependent increase of the number of leukocytes in the peripheral blood. Specifically, eosinophils, lymphocytes, and neutrophils were recruited with maximum effects seen 60 min after the injection of 300 μg of DK-PGD2 per rat. Pretreatment of the animals with the CRTH2/thromboxane A2 receptor antagonist, ramatroban, completely abrogated DK-PGD2-induced eosinophilia, suggesting that CRTH2 might have a physiological and/or pathophysiological role in controlling leukocyte migration.This publication has 21 references indexed in Scilit:
- An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in VitroThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2British Journal of Pharmacology, 2002
- Prostaglandin D 2 as a Mediator of Allergic AsthmaScience, 2000
- Molecular Cloning and Characterization of the Human Prostanoid DP ReceptorJournal of Biological Chemistry, 1995
- Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.Proceedings of the National Academy of Sciences, 1994
- Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: Relationship to the development of late asthmatic responsesJournal of Allergy and Clinical Immunology, 1991
- The biology and pharmacology of PGD2Prostaglandins, 1988
- Release of Prostaglandin D2into Human Airways during Acute Antigen ChallengeNew England Journal of Medicine, 1986
- A cell-surface molecule involved in organ-specific homing of lymphocytesNature, 1983
- Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compoundsNature, 1981